Treatment time for hemodialysis: What should it be?

ASAIO Journal

Volumn 43, Issue 3, 1997, Pages 225-227

  Port, Friedrich K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HEALTH CARE; HEMODIALYZERS; MEDICINE; PATIENT TREATMENT;

TREATMENT TIME;

DIALYSIS;

HEMODIALYSIS; HISTORY OF MEDICINE; HUMAN; MORTALITY; PRACTICE GUIDELINE; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0342276029     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199705000-00019     Document Type: Review

References (17)

1. United States Renal Data System: USRDS 1996 Annual Data Report, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1996.
2. Port FK, Johnson WJ, Klass DW: Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 3: 327-333, 1973; and Abstracts, Am Soc Nephrol Washington, DC, 1971:61.
3. Port FK, Johnson WJ, Klass DW: Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 3: 327-333, 1973; and Abstracts, Am Soc Nephrol Washington, DC, 1971:61.
4. Babb AG, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meter hypothesis. ASAIO Trans 17: 81, 1971.
5. Lowrie EG, Laird NM (eds): The National Cooperative Dialysis Study. Kidney Int 23(suppl 13): 1-122, 1983.
6. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 28: 526-534, 1985.
7. Held PJ, Pauly MV, Diamond L: Survival analyses of patients undergoing dialysis JAMA 257: 645-650, 1987.
8. Held PJ, Port FK, Garcia JR, Gaylin DS, Levin NW, Agodoa L: Hemodialysis prescription and delivery in the U.S.: Results from USRDS Case Mix Study. J Am Soc Nephrol 2: 328, 1991.
9. Port FK; Effect of co-morbid conditions on hemodialysis mortality (Presented at Clinical Science Symposium). J Am Soc Nephrol 4: 36P, 1993.
10. Held PJ, Port FK, Wolfe RA, et al: The dose of hemodialysis and patient mortality. Kidney Int 50: 557-565, 1996.
11. Levin NW, Stannard DC, Gotch F, Port FK: Comparison of mortality risk (RR) by Kt/V single pool (SP) vs. double pool (DP) analysis in diabetic and non-diabetic hemodialysis patients. Abstracts. J Am Soc Nephrol 6: 606; 1995.
12. Owen WF II, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993.
13. Daugirdas JT: The post:predialysis plasma urea nitrogen ratio to estimate Kt/V and nPCR; mathematical modeling and validation. Int J Artif Organs 12: 411-427, 1989.
14. Charra B, Calemard E, Laurent G: Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16: 35-44, 1996.
15. Wolfe RA, Gaylin DS, Port FK: Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int 42: 991-996, 1992.
16. Morbidity and Mortality of Dialysis. NIH Consensus Statement. National Institutes of Health 11: 1-33, 1993.
17. United States Renal Data System: Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis 20(Suppl 2): 32-38, 1992.